Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : AP-003
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : BetterLife Pharma
Deal Size : Undisclosed
Deal Type : Partnership
BetterLife Announces VirTrial, as Clinical Trial Patient Monitoring Partner
Details : BetterLife pharma and viral clear will be teaming up to conduct patient monitoring for imminent COVID 19 clinical trials in Australia to test the efficacy of AP-003, a proprietary interferon alpha 2b formulation.
Product Name : Anticovir
Product Type : Protein
Upfront Cash : Undisclosed
August 10, 2020
Lead Product(s) : AP-003
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : BetterLife Pharma
Deal Size : Undisclosed
Deal Type : Partnership